NIH Ivermectin Study Designed To Fail

The National Institutes of Health (NIH), currently in progress, $155 million Phase 3 Clinical Trial to “Study Repurposed Drugs to treat Covid-19” using Ivermectin will FAIL because they are administering Ivermectin without Zinc. For successful treatment of Covid-19, Zinc is required as an Ionophore to kill the Covid virus. Ivermectin (IVM) or Hydroxychloroquine (HCQ), alone, will not kill Covid. In addition, most Ivermectin Covid Treatment Protocols include D3 and C to enhance immune systems, plus an antibiotic to knock-down any bacterial infections to help the patient recover quickly. These also were not included in the NIH Study.

NIH has allowed and is allowing people to die because they do not include Ivermectin in their Approved Covid-19 Drug List (and they issue negative propaganda). With people dying from Covid-19, why is the NIH Ivermectin Study scheduled to be completed December, 2022, findings to be announced March, 2023, and study data to be available to approved entities September, 2023? In the 2-years between Study Announcement on April, 2021 and March, 2023 (planned Study Results) hundreds of thousands of avoidable Covid-19 deaths and millions of avoidable Covid-19 cases could occur worldwide.

References:
NIH ACTIV-6 Study Announcement
NIH ACTIV-6 Study Plan
Zelenko Protocol
FCCC I-MASK Protocol
FCCC I-MATH Protocol
FCCC I-RECOVER Protocol

Tags: , , ,

Trackbacks/Pingbacks

  1. November 2021 Conservative Article Reference List | Fatherly Advice and Rants - November 23, 2021

    […] The National Institutes of Health (NIH) Ivermectin Effectiveness Study Designed To Fail […]

  2. November 2021 Conservative Article Reference List | Fatherly Advice and Rants - November 15, 2021

    […] Ivermectin Covid NIH Study Results Due March 2023 – Meanwhile The CDC, FDA, and NIH (and other… […]

Leave a Reply